Dr Jeonghoon Han is Vice President, CDO and CFO of Medicine Development Division & Management Planning Division at Eutilex, an innovative immuno-oncology biotech company based in South Korea. He is responsible for Eutilex pipeline development, global regulatory approval and global marketing and commercialisation. In addition, he is also responsible for finance, human resource and fund raising for the company.
Dr Han has 7 year’s basic, translational, and clinical oncology research background as a research fellow in Harvard Medical School and gained his Ph.D. in UMDNJ (Univ. of Medicine & Dentistry in New Jersey). His strong scientific background helped in the establishment of building a competitive medical affairs’ strategies, as well as creating progressive specific preclinical and clinical trials in Asia Pacific.
Dr Han has 18 years of extensive and diverse experiences in medical affairs, marketing, and CRO at seven global pharmaceutical companies and one biotech company managing more than twenty different life-cycle-phase products in oncology and Immunology therapeutic area. His strong leadership and coaching helps to motivate teams to achieve positive outcomes through excellent communication to build strong relationship with stakeholders.